Trial Profile
A Multi-Center Phase II Trial of Capecitabine (Xeloda) in Combination With Cisplatin as First Line Chemotherapy in Patients With Metastatic Nasopharyngeal Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- Sponsors Roche
- 20 Nov 2015 New trial record